Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Dow
AstraZeneca
UBS
McKesson
Cantor Fitzgerald
Citi
Accenture
Daiichi Sankyo

Generated: June 24, 2018

DrugPatentWatch Database Preview

PLAQUENIL Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Plaquenil patents expire, and what generic alternatives are available?

Plaquenil is a drug marketed by Concordia Pharms Inc and is included in one NDA.

The generic ingredient in PLAQUENIL is hydroxychloroquine sulfate. There are fifteen drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the hydroxychloroquine sulfate profile page.
Drug patent expirations by year for PLAQUENIL
Pharmacology for PLAQUENIL
Medical Subject Heading (MeSH) Categories for PLAQUENIL
Synonyms for PLAQUENIL
(+-)-2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol sulfate (1:1) (salt)
118-42-3 (Parent)
2-((4-((7-Chloro-4-quinolinyl)amino)pentyl)ethylamino)ethanol sulfate (1:1) (salt)
2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol sulfate (1:1) (salt)
2-((4-((7-Chloroquinolin-4-yl)amino)-pentyl)(ethyl)amino)ethanol sulfate
2-((4-((7-chloroquinolin-4-yl)amino)pentyl)(ethyl)amino)ethan-1-ol sulfate
2-((4-((7-Chloroquinolin-4-yl)amino)pentyl)(ethyl)amino)ethanol sulfate
2-({4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino)ethan-1-ol; sulfuric acid
2-[[4-[(7-Chloro-4-quinolinyl)amino]pentyl]ethylamino]ethanol sulfate
2-[4-[(7-chloro-4-quinolyl)amino]pentyl-ethyl-amino]ethanol; sulfuric acid
2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol; sulfuric acid
2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol;sulfuric acid
4CH-007360
7-Chloro-4-[4-[ethyl-(2-hydroxyethyl)amino]-1-methylbutylamino]quinoline
7-Chloro-4-[4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-methylbutylamino]quinoline Sulfate
747-36-4
747H364
AB0015282
AC1L20PB
ACM1216432562
AI3-52706
AK-72909
AKOS015897337
AN-22118
ANW-43969
API0025948
AX8134190
BR-72909
C18H26ClN3O.H2O4S
C18H28ClN3O5S
CAS-747-36-4
CCG-39154
CHEMBL1690
CPD000525253
CS-8017
CTK8B4131
D02114
DSSTox_CID_27788
DSSTox_GSID_47811
DSSTox_RID_82563
DTXSID1047811
EINECS 212-019-3
Ercoquin
Ethanol, 2-((4-((7-chloro-4-quinolinyl)amino)pentyl)ethyl)amino-, (+-)-, sulfate (1:1) salt
Ethanol, 2-((4-((7-chloro-4-quinolinyl)amino)pentyl)ethylamino)-, sulfate (1:1)
Ethanol, 2-((4-((7-chloro-4-quinolinyl)amino)pentyl)ethylamino)-, sulfate (1:1) (salt)
Ethanol, 2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)-, sulfate (1:1) (salt)
Ethanol, 2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)-, sulfate (1:1) (salt) (8CI)
Ethanol, 2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]ethyl]amino]-, sulfate (1:1) (salt)
Ethanol, monosulfate
Ethanol, sulfate (1:1) (salt)
FT-0603511
HE068378
HMS1922O12
HMS2093O05
HY-B1370
HYDROXYCHLOROQINE SULFATE
HYDROXYCHLOROQUINE SULFATE
Hydroxychloroquine sulfate (JAN/USP)
Hydroxychloroquine sulfate [USP]
Hydroxychloroquine sulfate, >=98% (HPLC), powder
Hydroxychloroquine Sulfate, pharmaceutical secondary standard; traceable to USP, BP
Hydroxychloroquine sulfate, United States Pharmacopeia (USP) Reference Standard
Hydroxychloroquine sulphate
Hydroxychloroquine Sulphate 1.0 mg/ml in Methanol (as free base)
hydroxychloroquine; sulfuric acid
Hydroxychloroquinesulfate
Hydroxycloroquine sulfate, analytical standard
J10260
KB-219927
KS-00000GEU
KS-5311
LP070127
LS-66615
M567
MCULE-4122662001
MFCD00078203
MolPort-003-666-519
N4-(7-Chloro-4-quinolyl)-N1-ethyl-N1-(2-hydroxyethyl)-1,4-pentanediamine Sulfate
NCGC00095090-01
NCGC00095090-02
NCGC00159483-02
NCGC00159483-04
NSC 4375
NSC-4375
NSC-758663
NSC758663
Oxichlorochine Sulfate
Pharmakon1600-01503978
Plaquenil (TN)
Plaquenil sulfate
Plaquinol
PubChem15393
S-2011
s4430
SAM001246735
SCHEMBL41114
SPECTRUM1503978
SR-05000001881
SR-05000001881-2
ST24030764
ST51053501
TCMDC-123987
Toremonil
Tox21_111707
Tox21_111707_1
TR-024132
W-104413
Z1551900864

US Patents and Regulatory Information for PLAQUENIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Concordia Pharms Inc PLAQUENIL hydroxychloroquine sulfate TABLET;ORAL 009768-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Moodys
Federal Trade Commission
Cerilliant
Argus Health
Julphar
Healthtrust
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.